Untitled Quiz
48 Questions
4 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary characteristic of type 1 diabetes?

  • Increased beta cell production
  • Excessive insulin secretion
  • Insulin resistance
  • T-cell-mediated autoimmune attack (correct)
  • At what stage is someone with type 1 diabetes typically diagnosed?

  • After a viral infection only
  • Often when otherwise healthy and of healthy weight (correct)
  • When insulin sensitivity is significantly impaired
  • During periods of obesity
  • What environmental factor is suggested to potentially trigger type 1 diabetes?

  • Low-fat diets
  • Viral infections (correct)
  • High sodium intake
  • Increased physical activity
  • Which lifestyle factor is NOT associated with type 2 diabetes?

    <p>Consuming whole grains</p> Signup and view all the answers

    What primarily causes the insulin resistance seen in type 2 diabetes?

    <p>Defective response of body tissues to insulin</p> Signup and view all the answers

    Which dietary factor is linked to an increased risk of developing type 2 diabetes?

    <p>Sugar-sweetened drinks</p> Signup and view all the answers

    Which test is considered the gold standard for long-term monitoring of diabetes?

    <p>Glycosylated Hemoglobin (HbA1c)</p> Signup and view all the answers

    What does a lack of exercise contribute to in relation to type 2 diabetes?

    <p>7% of diabetes cases</p> Signup and view all the answers

    What is a common side effect associated with long-term use of metformin?

    <p>Interference with vitamin B12 absorption</p> Signup and view all the answers

    Which of the following is NOT a contraindication for metformin use?

    <p>Diabetic ketoacidosis</p> Signup and view all the answers

    What is the primary mechanism of action for sulfonylureas?

    <p>Inhibit KATP channels of β-cells</p> Signup and view all the answers

    In which situation would insulin therapy be administered intravenously?

    <p>Acute conditions like diabetic ketoacidosis</p> Signup and view all the answers

    Which of the following complications can arise from insulin therapy?

    <p>Hypoglycemia</p> Signup and view all the answers

    What health aspect does diabetes care specifically help improve?

    <p>Blood glucose, blood pressure, and cholesterol levels</p> Signup and view all the answers

    Which insulin delivery method is typically used for long-term therapy?

    <p>Subcutaneous injection</p> Signup and view all the answers

    Which acute complication is NOT associated with diabetes mellitus?

    <p>Coronary artery disease</p> Signup and view all the answers

    What is the primary role of insulin in the body?

    <p>To transport glucose into fat and muscle cells</p> Signup and view all the answers

    What triggers the release of insulin from the beta cells in the pancreas?

    <p>Rising levels of blood glucose after eating</p> Signup and view all the answers

    What condition occurs when glucose levels remain excessively high over time?

    <p>Acidosis</p> Signup and view all the answers

    Which hormone acts in opposition to insulin in glucose metabolism?

    <p>Glucagon</p> Signup and view all the answers

    What happens to blood glucose levels if insulin is insufficient or ineffective?

    <p>Cells absorb glucose poorly</p> Signup and view all the answers

    What is the effect of glycosuria on the body?

    <p>Higher osmotic pressure in urine</p> Signup and view all the answers

    Which type of diabetes is characterized by the loss of insulin-producing beta cells?

    <p>Type 1 diabetes mellitus</p> Signup and view all the answers

    What leads to polydipsia in patients with high blood glucose?

    <p>Increased fluid loss from dehydration</p> Signup and view all the answers

    What does moderate or large ketones in the urine indicate when accompanied by hyperglycemia?

    <p>Insulin deficiency and risk of DKA</p> Signup and view all the answers

    In the case of negative or small ketones, how often should blood glucose be checked?

    <p>Every 2 hours</p> Signup and view all the answers

    What is the recommended carbohydrate distribution for a child on a split mix regime?

    <p>6 meals with 70% of total calories in major meals and 30% in midmeals</p> Signup and view all the answers

    What should be done if a child with hyperglycemia exhibits vomiting and large ketones?

    <p>Send the child to the emergency department</p> Signup and view all the answers

    What percentage of energy intake should come from complex carbohydrates for a healthy dietary plan?

    <p>50-60%</p> Signup and view all the answers

    Which type of foods is classified as high glycemic index (GI)?

    <p>Corn flakes and chocolates</p> Signup and view all the answers

    For children on a multiple dose injection (MDI) regime, what is the guideline on mid meals?

    <p>Mid meals should have less than 10-15 grams of carbohydrate</p> Signup and view all the answers

    What impact does exercise have on insulin requirements in diabetic individuals?

    <p>Decreases insulin requirement</p> Signup and view all the answers

    Which of the following complications is most commonly associated with diabetes due to damage in small blood vessels?

    <p>Diabetic nephropathy</p> Signup and view all the answers

    What is the approximate percentage of deaths in diabetics attributed to coronary artery disease?

    <p>75%</p> Signup and view all the answers

    Which treatment is recommended to decrease the progression of diabetic nephropathy?

    <p>ACE-inhibitors</p> Signup and view all the answers

    What is the most frequent acute complication in diabetes?

    <p>Hypoglycemia</p> Signup and view all the answers

    What condition is characterized by damage to the blood vessels in the retina of the eye?

    <p>Diabetic retinopathy</p> Signup and view all the answers

    Which of the following groups is primarily affected by sensory-motor polyneuropathy in diabetic patients?

    <p>Feet</p> Signup and view all the answers

    Which of the following is NOT a sign of diabetic nephropathy?

    <p>Increased glomerular filtration rate</p> Signup and view all the answers

    Which lifestyle change is recommended for diabetic patients to help manage their condition?

    <p>Smoking cessation</p> Signup and view all the answers

    What condition is indicated by painless ulceration and decreased deep tendon reflexes?

    <p>Diabetic neuropathy</p> Signup and view all the answers

    What is a potential effect of autonomic neuropathy in diabetic patients?

    <p>Diabetic diarrhea</p> Signup and view all the answers

    What was the objective of the study on the effects of mechanical vibration in patients with type 2 diabetes mellitus?

    <p>To determine impact on transcutaneous oxygen levels</p> Signup and view all the answers

    In the study on whole body vibration, what increase was observed in transcutaneous oxygen levels?

    <p>7 mmHg</p> Signup and view all the answers

    Which of the following symptoms should be assessed in a patient's history during a nursing assessment?

    <p>Polyuria, polydipsia, and polyphagia</p> Signup and view all the answers

    Which nursing diagnosis relates to the intake of excess foods compared to activity expenditures?

    <p>Imbalanced nutrition: more than body requirements</p> Signup and view all the answers

    What is one reason to collect a patient's family history in diabetic nursing assessment?

    <p>To identify potential genetic predispositions</p> Signup and view all the answers

    Which aspect is NOT part of the physical examination during a nursing assessment?

    <p>Changes in skin temperature</p> Signup and view all the answers

    Study Notes

    Definition of Diabetes Mellitus

    • A metabolic disorder with multiple causes.
    • Characterized by ongoing high blood sugar.
    • Caused by problems with insulin secretion, insulin action, or both.
    • Results in disturbances in carbohydrate, fat, and protein metabolism.

    Old Classification (1985)

    • Type 1: Insulin-dependent (IDDM)
    • Type 2: Non Insulin-dependent (NIDDM)
      • Obese
      • Non-obese
    • MODY (Maturity-onset diabetes of the young) - onset between 18-25 years old.
    • IGT (Impaired glucose tolerance)
    • Gestational Diabetes Mellitus

    New Classification (WHO)

    • Based on the cause (etiology), not the treatment or age of the patient.
    • Type 1: Beta cell destruction - Absolute insulin deficiency
      • Immune mediated
      • Idiopathic
    • Type 2: Predominant insulin resistance with some relative insulin deficiency.
      • Predominant secretory defect with insulin resistance

    Other Specific Types

    • Genetic defect of beta cell function (MODY syndromes)
    • Mitochondrial mutations
    • Infections (congenital rubella, CMV)
    • Pancreatic disease (pancreatitis, trauma/pancreatectomy, neoplasia)
    • Cystic fibrosis
    • Endocrinopathies (Acromegaly, Cushing's Syndrome, Pheochromocytoma)
    • Drug or chemical induced (nicotinic acid, glucocorticoids, thiazides)
    • Genetic disorders (Down syndrome, Turner syndrome, Klinefelter syndrome, Prader-Willi syndrome)
    • Gestational Diabetes Mellitus
    • Neonatal Diabetes Mellitus

    Type 1 Diabetes Mellitus

    • Formerly called insulin-dependent diabetes mellitus (IDDM) or juvenile diabetes.
    • Characterized by low or absent levels of endogenously produced insulin.

    Epidemiology

    • Most common endocrine disorder of childhood and adolescence.
    • Onset predominantly in childhood, with two peaks: one at 5-7 years and one at puberty, but can occur at any age.
    • In India, the average prevalence of type 1 diabetes is 10 per 100,000 population.
    • Risk of development:
      • Mother with type 1 DM: 2% risk in child
      • Father with type 1 DM: 7% risk in child
      • Sibling with type 1 DM: 6% risk
      • Dizygotic twins: 6-10% risk
      • Monozygotic twins: 30-65% risk

    Pathogenesis & Natural History

    • The natural history of type 1 diabetes includes distinct stages:
      • Initiation of autoimmunity
      • Preclinical autoimmunity with progressive ẞ-cell loss
      • Onset of clinical disease
      • Transient remission ("honeymoon period")
      • Established disease
      • Development of complications

    The Pancreas

    • Key components:
      • Islet of Langerhans
        • Beta cells: secrete insulin
        • Alpha cells: secrete glucagon
    • Autoimmunity is a major factor in damaging β-cells

    Pathogenesis of Type 1 Diabetes

    • Immune dysregulation
    • Environmental triggers and regulators
    • Interactions between genes
    • Variable insulitis
    • B-cell sensitivity to injury
    • Loss of first-phase insulin response
    • Glucose intolerance
    • Absence of C-peptide
    • Prediabetes (IGT)
    • Overt Diabetes

    Clinical Presentations

    • DKA (most common presentation in pediatrics)
    • Clinical symptom triad:
      • Polyuria
      • Polydipsia
      • Weight loss
    • Accidental diagnosis

    Diagnostic Criteria

    • Symptomatic children (polydipsia, polyuria, weight loss): random plasma glucose >11.1 mmol (200 mg) is diagnostic.
    • Hemoglobin A1c (HbA1c) ≥ 6.5%
    • Modified OGTT (oral glucose tolerance test) may be needed in asymptomatic children with hyperglycemia (>140) or symptomatic patients with hyperglycemia (random blood sugar between 140 and 400)

    Treatment Elements

    • Education
    • Insulin therapy
    • Glycemic control monitoring.
    • Diet and meal planning
    • Prevention and early detection of complications

    Education

    • Educate children and caregivers about:
      • Type 1 diabetes
      • Life-long insulin therapy
      • Self-monitoring and record-keeping
      • Recognition of hypoglycemia and ketoacidosis
      • Meal planning
      • Sick-day management
      • Potential long-term complications

    Insulin Therapy

    • Insulin is a polypeptide made up of two β-chains.
    • It was discovered by Bants & Best in 1921.
    • Animal types (porcine and bovine) were initially used before human-like insulin (DNA-recombinant types).
    • More potent insulin analogs are now available via changing the aminoacid sequences.
    • Various types exist with different onsets, peak times, and durations of action (rapid-acting, short-acting, intermediate-acting, long-acting, premixed).

    Insulin Pump Therapy

    • Continuous subcutaneous insulin infusion (CSII) using battery-powered pumps provides a closer approximation of normal plasma insulin profiles
    • Accurately delivers a small baseline continuous infusion of insulin, coupled with bolus therapy.
    • Bolus insulin is determined by the amount of carbohydrates ingested and the current blood sugar levels.

    Monitoring of Glycemic Control

    • Self-monitoring of blood glucose (measuring fasting levels; before and 2 hours after meals; during nighttime)
    • Real-time continuous glucose monitoring
    • Urinary glucose (reflects glycemic levels over several hours)
    • Measuring ketones in urine (more sensitive and accurate for high blood sugar >250mg/dL, or illnesses such as fever or vomiting combined with abdominal pain, polyuria, or rapid breathing)
    • Glycosylated Hemoglobin (HbA1c) monitoring every 3–4 months

    Adverse Effects of Insulin

    • Hypoglycemia
    • Lipoatrophy
    • Lipohypertrophy
    • Obesity
    • Insulin allergy
    • Insulin antibodies

    Practical Problems

    • Non-availability of insulin in low-income countries
    • Injection site and technique issues
    • Insulin storage and transfer issues
    • Mixing insulin preparations
    • Insulin and school schedule adjustments
    • Sick-day management
    • Home recognition and treatment of hypoglycemia

    Management on Sick Days

    • Insulin requirement may increase or decrease during illness.
    • Fever, dehydration, stress of illness may cause hyperglycemia; vomiting, loss of appetite, may result in hypoglycemia.
    • Risk of ketoacidosis is increased due to starvation and dehydration.
    • Ensure adequate fluid intake and frequent monitoring of blood glucose and urine ketones.

    Diet Regulation

    • Regular meal plans and calorie exchange options are encouraged.
    • 50-60% of required energy should be from complex carbohydrates.
    • Carbohydrate intake should be evenly distributed throughout the day, preferably with 3 meals & 2 snacks, avoiding simple sugars.
    • Encourage a low-salt, low-saturated fat diet with high fiber.
    • Avoid simple sugars.
    • For split mix regimens: 6 meals, 3 major(70%), 3 mid-meals (30%).
    • Medial meals not essential in children with MDI regimen, with ≤ 10-15g carbohydrates.
    • Glycemic Index is the ranking of carbohydrates on a scale of 0 - 100, based on the extent to which they raise blood sugar levels after ingestion.
    • Low GI foods are preferred (e.g., most fruits and vegetables (except potatoes & watermelon), pasta, pulses, milk, and curd. )

    Exercise

    • Decreases insulin requirement in diabetic subjects by increasing muscle cell sensitivity to insulin and enhancing glucose utilization.
    • Can precipitate hypoglycemia in unprepared diabetic patients.
    • Exercise caution if blood sugar is high (>250mg/dl) or urine ketones are present.
    • Wear proper footwear and avoid extremes of heat or cold during activity.
    • Have snacks after exercise to prevent post-exercise hypoglycemia

    Pitfalls of Management

    • Delayed diagnosis of IDDM
    • The honey-moon period
    • Problems with diagnosis & treatment of DKA & hypoglycemia
    • Somogyi effect & dawn phenomenon may go unrecognized.

    Dawn Phenomenon

    • Blood glucose levels increase in early morning hours before breakfast due to declining insulin levels (resulting in elevated morning glucose).
    • This phenomenon is mainly caused by overnight growth hormone secretion and increased insulin clearance.
    • It's a normal physiological process among most adolescents who compensate with higher insulin output.
    • Children with Type 1 DM cannot compensate.

    Somogyi Phenomenon

    • Theoretical rebound from late-night or early morning hypoglycemia thought to be from an exaggerated counter-regulatory response.
    • Continuous glucose monitoring systems or night-time blood glucose monitoring can detect and clarify ambiguously elevated morning glucose levels.

    Complications of Diabetes

    • Acute:
      • Diabetic ketoacidosis (DKA)
      • Hypoglycemia
      • Hyperosmolar coma
    • Late-onset:
      • Retinopathy
      • Neuropathy
      • Nephropathy
      • Ischemic heart disease & stroke

    Guidelines Regarding Monitoring for Complications

    • HbA1c: 3-4 times per year
    • Height/Weight: 3-4 times per year
    • Nutritional counseling: At diagnosis, 4-6 weeks later, then annually.
    • Lipid profile: Pubertal children every 5 years; pre-pubertal children within 6-12 months of diagnosis, then annually after 10 years old.
    • Blood pressure: Annually after age 10 years.

    Prevention and Early Detection of Complications

    • Retinopathy
      • Screening (after 5 years in prepubertal children; after 2 years in pubertal children)
      • Frequency: 1-2 yearly
      • Method: Fundal photography
    • Nephropathy
      • Screening (after 5 years in prepubertal children; after 2 years in pubertal children)
      • Frequency: annually
      • Method: Spot urine sample for albumin:creatinine ratio
    • Neuropathy
      • Screening (unclear in children; adults at diagnosis of Type 2 DM and 5 years after diagnosis of type 1 DM)
      • Frequency: unclear
      • Method: Physical examination
    • Macrovascular disease
      • Screening: after age 2 years
      • Frequency: every 5 years
      • Method: lipid profile test

    Thyroid Disease

    • Screening: at diagnosis
    • Frequency: every 2-3 years or more frequently based on symptoms or antithyroid antibodies.
    • Method: TSH

    Celiac Disease

    • Screening: at diagnosis
    • Frequency: every 2-3 years
    • Method: tissue transglutaminase and endomysial antibody

    Management of Acute Complications

    • Diabetic Ketoacidosis

    Diabetic Ketoacidosis

    • A life-threatening complication of diabetes mellitus, more common in children with Type 1 DM than Type 2 DM.
    • Defined by hyperglycemia (>200-300 mg/dL), metabolic acidosis (blood pH <7.3 with serum bicarbonate <15 mEq/L), and ketonemia (presence of ketones in blood).

    Signs and Symptoms of Diabetic Ketoacidosis

    • Nausea, vomiting, abdominal pain
    • Fruity odor in breath
    • Tachycardia
    • Low-volume pulses
    • Hypotension
    • Impaired skin turgor
    • Delayed capillary refill time
    • Dehydration
    • Rapid, deep sighing (Kussmaul) respirations

    Classification of Diabetic Ketoacidosis

    • Normal
    • Mild
    • Moderate
    • Severe

    Diabetic Ketoacidosis Treatment Protocol

    • Replace fluids (10-20 mL/kg of 0.9% NaCl or LR intravenously)
    • Administer insulin drip (0.05-0.1U/kg/hr for children)
    • Potassium phosphates (20mEq/L) and (0.5 - 2.5% glucose)
    • Treat hypokalemia (if low: 0.5 - 1 mEq/kg)
    • Monitor for emesis, CO2, and electrolytes Note: Should be taken to emergency department if vomiting and large ketones are present, or frequent hypoglycemia occurs.

    Transition to Subcutaneous Insulin Therapy

    • As oral feeds advance, IV fluids are reduced and the change to subcutaneous insulin is planned.
    • Administer immediate rapid-acting insulin prior to each meal (e.g., lispro or aspart 15-30 minutes before or regular 1-2 hours before the IV insulin infusion is discontinued), followed by a regular (or short acting) insulin.
    • The optimal dose of subcutaneous insulin therapy is 0.75 – 1 U/kg /day (pre-pubertal) and 1-1.2 U/ kg/day (pubertal)

    Management of Cerebral Edema

    • Elevate the patient's head.
    • Administer Mannitol 0.5-1 g/kg intravenously; repeat as needed every 30-120 minutes if there is no response
    • Administer 3% hypertonic saline 5ml/kg intravenously over 30 minutes

    Non-Ketotic Hyperosmolar Coma

    • Severe hyperglycemia (>800 mg/dL)
    • Absence or minor ketosis.
    • Severe dehydration
    • Depressed sensorium or coma
    • Miscellaneous neurological signs (seizures, hyperthermia, hemiparesis, and positive Babinski signs)

    Treatment of Non-Ketotic Hyperosmolar Coma

    • Rapid fluid replacement with 0.45% NaCl (one-half of volume deficit in 1-12 hours, remainder in the next 24 hours)
    • Change to 5% dextrose in 0.2 normal saline when blood glucose levels approach 300 mg/dL.
    • Add potassium chloride (20 mEq/L) to fluids to correct hypokalemia.
    • Administer insulin (0.05 units/kg/hr, intravenously) after 2 hours of fluid therapy

    Hypoglycemia

    • Blood glucose <70 mg/dL. Risks increase with the duration of diabetes.
    • Mild to moderate symptoms: Immediate oral consumption of 0.3 g/kg of glucose drink or candy (retesting every 10–15 minutes for adequate response and re-administering if inadequate).
    • Severe symptoms: Altered mental status (unconsciousness, or seizures): Administer glucagon 0.5 mg intravenously for children under age 12; administer 1mg for over 12 years

    Management of Hypoglycemia

    • Mild: Oral fast-acting carbohydrates (10–15 g).
    • Severe (semi-conscious or comatose): Intravenous hypertonic glucose (25% or 50% concentration) and glucagon 1mg intravenously

    Diabetic Ketoacidosis

    • Life-threatening complication.
    • Causes: Omitting insulin, infections, trauma, myocardial infarction, stroke, surgery, emotional stress
    • Mortality rate: ~5%

    Clinical Presentation of Diabetic Ketoacidosis

    • Vomiting
    • Sleepiness
    • Stomach pain
    • Rapid breathing
    • Increased pulse
    • Dry mouth
    • Flushed face
    • Fruity breath

    Management of Diabetic Ketoacidosis

    • Fluid replacement (0.9% NaCl IV)
    • Insulin therapy (50 Units insulin in 50ml NS IV via infusion pump; 6U/hr initially; 3U/hr when < 270mg/dL; 2U/hr when < 180mg/dL).
    • Electrolyte correction
    • Correction of acidosis
    • Treatment of precipitating cause

    Hyperglycemia, Hyperosmolar

    • Occurs when there is insufficient insulin to prevent hyperglycemia but enough insulin to prevent ketoacidosis.
    • Occurs in all types of diabetes, especially Type 2.
    • Life-threatening medical emergency.
    • Characterized by extremely high glucose levels(>800mg/dl,) & clinical presentation with osmolarity (>340 mOsm/L)

    HHNKS (Hyperglycemia, Hyperosmolar Nonketotic Syndrome)

    • Major difference from Diabetic Ketoacidosis: lack of ketonuria (residual ability to secrete insulin in NIDDM).
    • Clinical presentation: Altered level of consciousness (lethargy to coma), neurological deficits (hyperthermia, motor and sensory impairment, seizures), dehydration (dry skin and mucous membranes, extreme thirst).

    Macrovascular Complications

    • Ischemic heart diseases.
    • Cerebrovascular diseases.
    • Peripheral vascular diseases.
    • Diabetic patients have a 2–6 times higher risk.

    Hypertension in DM

    • Commonly present at diagnosis.
    • Affects about 60% of patients.
    • Secondary to insulin resistance.
    • Increases the risk of retinopathy and nephropathy.
    • Abnormal lipid profile, predominantly low HDL and high triglycerides is common

    Peripheral Vascular

    • Increased risk in type 1 & 2 diabetes.
    • Risk of arterial occlusion and thrombosis resulting in gangrene.
    • Gangrene is the most common cause of non-traumatic lower limb amputation

    Screening for Macrovascular Complications

    Examine pulses for cardiovascular diseases.

    • Lipid profile.
    • ECG
    • Blood pressure

    Microvascular Complications

    • Microvascular complications are specific to chronic hyperglycemia.
    • Type 1 and 2 DM susceptible to microvascular complications.
    • Duration and quality of diabetic control are significant determining factors for microvascular abnormalities.

    Diabetic Retinopathy

    • Affects 60% of Type 2 diabetics.
    • Progressive, irreversible vision loss.
    • Damage to the tiny blood vessels in the retina.
    • Presence of: Micro aneurysms, scattered exudates, cotton wool spots.

    Diabetic Nephropathy (DN)

    • Defined by persistent albuminuria (>300 mg/day), decrease glomerular filtration rate, and rising blood pressure.
    • About 20-30% of diabetes patients develop diabetic nephropathy.
    • Manifested by microalbuminuria.
    • Progressive diabetic nephropathy leading to end-stage renal disease

    Treatment to Prevent Diabetic Complications

    • Screen all diabetic patients annually for microalbuminuria.
    • Tight glycemic control and blood pressure management.
    • ACE inhibitors are recommended to mitigate nephropathy progression.
    • Smoking cessation.
    • Protein restriction.
    • Lipid reduction.

    Diabetic Neuropathy

    • Damage to nerves throughout the body due to hyperglycemia.
    • Types: Sensory-motor polyneuropathy, Autonomic neuropathy.
      • Sensory-motor polyneuropathy: numbness, paresthesias, mostly feet/less frequently hands; potential complications include painful ulceration (painless), Charcot arthropathy, and decreased deep tendon reflexes.
      • Autonomic neuropathy: Affects many bodily systems with clinical presentation of orthostatic hypotension, diabetic diarrhea, erectile dysfunction, difficulty urinating

    Research Input

    • Effect of mechanical vibration on transcutaneous oxygen levels in the feet of type 2 diabetes mellitus patients.
    • To determine whether whole-body vibration favorably impacts certain parameters related to diabetic foot syndrome, specifically transcutaneous oxygen levels above 40 mmHg.

    Method

    • 54 patients with DM participated in a 12-week exercise program based on whole-body vibration.
    • The study determined glycemic control through patients' HbA1c levels.
    • TcPO2 was recorded on each patient's foot.

    Results

    • A statistically significant increase was observed in the TcPO2 level (7mmHg).

    Conclusion

    • Whole-body vibration potentially elevates TcPO2 levels and may be useful in preventing or managing complications from diabetic foot syndrome with restricted blood perfusion

    Diabetes Prevention 101

    • Monitor and/or lower your blood pressure and cholesterol.
    • Manage your weight and body mass index (BMI).
    • Quit smoking.
    • Maintain a healthy diet (decrease fat intake; increase fiber intake; add more whole grains, fruits, vegetables, lean meats).
    • 30 minutes of daily activity five days per week, potentially reducing the risk of developing type 2 diabetes by 58%.

    Nursing Management

    • Obtaining a thorough patient history, including current and general health, family history, symptoms experienced (polyuria, polydipsia, polyphagia), length of time since diagnosis, and symptoms of complications.
    • Performing a thorough physical examination, encompassing general condition (weight loss/gain, fatigue, and anxiety), skin (lesions, infections, and dehydration assessment); eyes (vision changes, “floaters,” halos; and cataracts); cardiovascular (orthostatic hypotension, and claudication); gastrointestinal (diarrhea, increased hunger and thirst); genitourinary (polyuria, nocturia); and neurological (numbness and tingling) assessment

    1. Imbalanced Nutrition

    • Assess current meal timings and content.
    • Advise patient on individualized meal plan and weight loss goals.
    • Explain the importance of exercise in maintaining/reducing weight.
    • Assist patient in creating goals for weekly weight loss and provide incentives.

    2. Risk for Injury (Hypoglycemia)

    • Closely monitor blood glucose levels to detect hypoglycemia.
    • Instruct the patient on the accuracy of insulin preparation and meal timings to avoid hypoglycemia.
    • Quickly treat hypoglycemia with 15-20 g of fast-acting carbohydrates.
    • Teach the patient for carrying sugar candy or cubes and wearing an identification bracelet.

    3. Deficient Knowledge

    • Assess patient's knowledge of the disease and ability to care for themselves.
    • Assess their adherence to the prescribed diet, monitoring procedures, medication, treatment, exercise regimen.
    • Assess for signs of hyperglycemia or hypoglycemia.
    • Perform skin and extremity assessments for peripheral neuropathy or injuries of feet.

    4. Risk for Impaired Skin Integrity

    • Assess feet and legs for skin temperature variations/soft tissue injuries, presence of corns, dryness, hammer toes.
    • Ensure patient safety by ensuring foot protection from break down; use heel protectors, special mattresses, and foot cradles for bed-ridden patients.
    • Avoid using drying agents such as alcohol on skin; use moisturizers tomaintain skin elasticity and prevent the formation of fissures.
    • Instruct patients in foot care guidelines

    5. Ineffective Coping

    • Discuss diabetes' perceived effect on lifestyle, finances, family life, and occupation.
    • Explore prior coping strategies and skills.
    • Encourage patient and family involvement in diabetes self-management.
    • Provide emotional support to the patient and family.

    Special Patient Population

    • Adolescent Type 2 Diabetes Mellitus
    • Type 2 DM is on the rise among adolescents.
    • Lifestyle modification is essential for these patients, and metformin may be initiated as an oral medication.

    Definitions

    • Endocrinology : the study of hormones, glands, diabetes, and thyroid.
    • Hormones: biologically active substances secreted by glands
    • Endocrine: hormones have effects far away
    • Paracrine: hormones have effects nearby
    • Autocrine: hormones have local effects

    Hormone Classification

    • Proteins: thyroid stimulating hormone, insulin, parathyroid hormone
    • Amino Acids: thyroid hormone, epinephrine
    • Steroids: cortisol, aldosterone, testosterone

    Mechanism of Action of Hormones

    • Hormones circulate in blood streams, bound to carrier proteins or free.
    • Free hormones are the active hormones.
    • Enter cells to alter biological activity

    Coordination of Body Functions

    • Nervous systems: neurotransmitters into synaptic junctions.
    • Endocrine systems: hormones into blood by secretions.
    • Neuroendocrine: neurohormones into blood
    • Paracrine hormones: secreted into the extracellular fluid; affects neighbors
    • Autocrine hormones: affect the same cells
    • Cytokines: peptides (interleukins, lymphokines), adipokines (leptin)

    Blood Sugar Control

    • Hyperglycemic: >120mg %; insulin causes body cells to take up glucose, livers store glucose as glycogen
    • Hypoglycemic: <80 mg %; glucagon stimulates liver to break down glycogen into glucose

    Type 1 Diabetes

    • Also known as Juvenile diabetes (IDDM) or Insulin Dependent
    • Characterized by low endogenous insulin production.
    • Pronounced hyperglycemia (frequently presenting with polydipsia, polyphagia, and polyuria; weakness; and weight loss).
    • Patients left untreated may result in ketoacidosis.

    Type 2 Diabetes

    • Also known as Adult-onset diabetes (NIDDM) ,
    • Results from inadequate insulin binding to cells. Results in less pronounced hyperglycemia,
    • Accounts for 90% of all diagnosed cases.

    Risk Factors for Type-2 Diabetes

    • Age (45 or more),
    • Race (e.g., African American, Asian American, Hispanic or Latino)
    • Family history (parents, siblings with diabetes)
    • Pre diabetes,
    • Cardiovascular disease,
    • Hypertension,
    • Low HDL cholesterol,
    • high triglycerides.
    • Obesity,
    • Polycystic ovary syndrome,
    • Physical inactivity,
    • Saturated and trans fat in diet,
    • Frequent sugar-sweetened drinks.
    • Central nervous system involvement includes polydipsia, polyphagia, lethargy, and stupor.
    • Weight loss
    • Systemic symptoms with polyuria.
    • Respiratory symptoms include Kussmaul breathing.
    • Gastrointestinal symptoms include nausea, vomiting, abdominal pain.
    • Eyes may be affected with blurred vision.
    • Urinary signs/symptoms include polyuria and glycosuria.
    • Breath may have an acetone-like odor.

    Type 1 Summary

    • Autoimmune pancreatic destruction
    • Need for insulin replacement therapy.
    • Often/frequently present with diabetic ketoacidosis(DKA)
    • At risk of other autoimmune diseases.
    • Evaluation of coping strategies is an important part of care.

    Type 2 Summary

    • Usually not obese,
    • Frequently diagnosed with diabetic ketoacidosis (DKA)
    • Require exogenous insulin in cases of metabolic decompensation.

    Diabetes Epidemiology

    • Globally, the incidence of diabetes is significantly increasing by 2-5% each year.
    • In Europe, the Middle East, and Australia, the incidence rates for Type 1 diabetes are increasing by 2–5% annually.
    • The prevalence of type 1 diabetes is highest in Scandinavian countries (20% of the total diabetes population), whereas, the lowest rates are found among people in China and Japan (<1%).
    • Type 1 DM is more common in males than in females.
    • In populations of European origin, the male-to-female ratio is generally greater than 1.5:1.
    • Type 1 DM is most frequently diagnosed in non-Hispanic whites, and less frequently in African Americans and Hispanic Americans.
    • It is comparatively uncommon in Asians.

    Prognosis for Type 1 Diabetes

    • High risk of morbidity and premature mortality.
    • More than 60% of patients with Type1 DM will not develop serious complications in the long term; but those with ongoing chronic complications might experience early death, blindness, end-stage renal disease (ESRD), or other complications.

    Patient Education for Type 1 Diabetes

    • Education is a critical aspect of diabetes management, coordinating by the patient’s long-term diabetes care team.
    • Make patients aware of the signs and symptoms, particularly related to hypoglycemia, and educate them on how to recognize and manage the condition appropriately.
    • Provide dietitians to educate patients and their families about dietary control.
    • Nurses/Health care providers should educate patients on self-insulin injection techniques & monitoring blood glucose through fingerstick tests.

    Self-monitoring of Glucose levels

    • Symptoms of a cold, flu, or other intercurrent illness (nausea, vomiting, abdominal pain, polyuria)
    • An unexpectedly high glucose level on monitoring
    • Persistent, rapid, and marked fluctuation in the degree of hyperglycemia

    Self-Monitoring of Blood Glucose (SMBG) Levels

    • A blood sample is placed onto a test strip,
    • The test strip is inserted into a blood glucose meter
    • Fasting/Pre-meal blood glucose levels are typically 70-100 mg/dL.
    • Post-meal blood glucose levels are typically 70-140 mg/dL.

    Diabetes Care Schedule

    • Every 3 months: Doctor's office visit, HbA1c blood test, blood pressure, weight, and foot check
    • Every 6 months: HbA1c blood test (if glucose levels are stable); teeth and gums evaluation by dentist
    • Yearly: Complete physical exam, foot exam, lipid profile test, eye exam, flu shot, and kidney test

    Continuous Glucose Monitoring (CGM)

    • Provides real-time interstitial glucose levels every 1-5 minutes.
    • Provides alarms for high or low glucose readings & rapid fluctuations.
    • Used in conjunction with transcutaneous or subcutaneous sensors, based on device use

    Management of Hypoglycemia(Symptoms of low blood sugar)

    • Mild: Administer oral fast-acting carbohydrates (10–15 g).
    • Severe: Administer intravenous hypertonic glucose (25% or 50% concentration) and glucagon 1mg intravenously,

    Diabetic Ketoacidosis (DKA) Causes/Triggers

    • Missed or omitted insulin doses in Type 1 DM patients.
    • Infections
    • Trauma
    • Myocardial infarction
    • Stroke
    • Surgery
    • Emotional stress

    Diabetic Ketoacidosis (DKA) Clinical Presentation

    • Vomiting
    • Lethargy/sleepiness
    • Stomach pain
    • Rapid deep breathing
    • Increased pulse
    • Dry mouth
    • Flushed face
    • Fruity breath

    Diabetic Ketoacidosis Management

    • Fluid replacement with 0.9% NaCl IV.
    • Insulin therapy with 50U insulin in 50 mL NS IV via infusion pump (6U/hr; reducing to 3U/hr when <270mg/dL; reducing to 2U/hr when <180mg/dL).
    • Electrolyte correction
    • Correction of acidosis
    • Treatment of the precipitating factor.

    Pancreas & Islet Cell Transplantation

    • Pancreas transplantation for end-stage renal disease.
    • Islet cell transplantation- is a potential treatment option; however, graft rejection and recurrence of autoimmunity are limitations.

    Immune Modulation

    • Immunosuppressive therapy (for newly diagnosed patients, patients in the prolonged honey-moon period, and high-risk children)
    • Immunomodulating drugs (e.g., nicotinamide and mycophenolate).

    Gene Therapy

    • Immunological attack against islet cells by introducing DNA-plasmids coding for self antigens
      • Using cytokine inhibitors.
      • Modifying antigens like GAD65

    Prediction of Diabetes

    • Sensitive and specific immunologic markers: GAD, GLIMA, IA-2 antibodies.
    • Consider the risk associated with single or multiple antibody positivity during diagnosis.

    Prevention of Diabetes

    • Primary prevention: Identification of diabetes genes, prevention of autoimmune factors/environmental triggers
    • Secondary prevention: Immunosuppressive therapy
    • Tertiary prevention: Tight glycemic control and monitoring

    Conclusions

    • Hormones are essential for normal growth, development, metabolism, energy requirements, and reproduction.
    • Hormonal activity/secretion is tightly regulated by multiple systems within the body.
    • Over or under production of hormones is linked to clinical diseases.

    Type 2 Diabetes Mellitus (T2DM) Pathogenesis

    • Multifactorial etiological factors & complex pathophysiology
    • Combinations of genetic predisposition, environmental factors, and lifestyle choices.

    Type 2 Diabetes Mellitus (T2DM) Natural History

    • The development of prediabetes, characterized by elevated fasting blood glucose or impaired glucose tolerance (IGT).
    • The diagnosis of type 2 diabetes, characterized by elevated fasting blood glucose and/or impaired glucose tolerance.
    • The progression of disease- with the gradual decline in β-cell function, as well as insulin resistance progressing.
    • Macrovascular changes (e.g., coronary artery disease).
    • Microvascular changes (e.g., diabetic neuropathy, nephropathy).

    Type 2 Diabetes Mellitus (T2DM) Classifications

    • Classic view: Insulin resistance, and a deficiency of incretin.
    • There is a deficiency in β-cell function, which leads to inadequate secretion of insulin.

    Role of Intestines

    • Secretes digestive enzymes into the small intestine.
    • Endocrine tissues secrete hormones such as GLP-1

    Role of Intestine in Diabetes

    • Gut microbiota plays a significant role in diabetes by influencing several factors including metabolism, immunity, and the activity of several hormones.

    Role of the Brain

    • Sympathetic Nervous System and Insulin Secretion
    • Parasympathetic Nervous System and Insulin Secretion

    Alzheimer's Disease (AD)

    • Proposed as type 3 diabetes (T3DM).
    • Features insulin resistance within the brain.
    • Presence of insulin and insulin-like growth factor (IGF) receptors within neurons.
    • Insulin resistance is observable in patients with AD

    Role of Sleep Deprivation in Diabetes

    • Sleep deprivation and prolonged wakefulness may disrupt the body's diurnal patterns of hormone secretion, such as leptin, glucagon, insulin, and melatonin.
    • Sleep disruption can result in significant impacts on glucose metabolism.

    Role of Inflammation in Diabetes

    • Obesity leads to systemic inflammation.
    • Preclinical evidence reveals links between systemic inflammation and β-cell dysfunction.
    • Inflammatory markers (e.g., CRP, IL-6) and its upstream regulators demonstrate association with insulin sensitivity and β-cell function.

    Role of Environmental Factors in Diabetes

    • Energy expenditure and caloric intake
    • Environmental chemicals,
    • Gut microbiome,
    • Body adiposity genes are also considered environmental factors that influence the risk for type 2 diabetes

    Association Between Maternal Smoking, Obesity, and Offspring Diabetes

    • Several studies show a relationship between maternal smoking during pregnancy, potential for overweight/obesity, and an increased risk for developing diabetes in the offspring.

    Association Between Arsenic and Diabetes

    • Several studies demonstrate a correlation between arsenic exposure and the risk of developing diabetes among populations experiencing high levels of arsenic exposure.

    Classic View of Type 2 Diabetes.

    • Classic view suggests a combination of factors including insulin resistance and β-cell deficiency to result in hyperglycemia.

    Summary

    • Describes the various mechanisms and factors that work together to cause both Type 1 and Type 2 DM and subsequent disease complications.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Diabetes 3 PDF

    More Like This

    Untitled Quiz
    37 questions

    Untitled Quiz

    WellReceivedSquirrel7948 avatar
    WellReceivedSquirrel7948
    Untitled Quiz
    55 questions

    Untitled Quiz

    StatuesquePrimrose avatar
    StatuesquePrimrose
    Untitled Quiz
    50 questions

    Untitled Quiz

    JoyousSulfur avatar
    JoyousSulfur
    Untitled Quiz
    48 questions

    Untitled Quiz

    StraightforwardStatueOfLiberty avatar
    StraightforwardStatueOfLiberty
    Use Quizgecko on...
    Browser
    Browser